National Research Corp Aktie
31,60 €
Deine Einschätzung
National Research Corp Aktie
Was spricht für und gegen National Research Corp in den nächsten Jahren?
Pro
Kontra
Rendite von National Research Corp im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
National Research Corp | 0,64 % | - | - | - | - | - | - |
H&E Equipment Services Inc. | 0,92 % | 0,92 % | -7,56 % | 68,71 % | 15,55 % | 65,66 % | 101,50 % |
Newtek Business Services Inc. | 0,97 % | 1,66 % | 2,46 % | 0,48 % | -18,43 % | - | - |
Mistras Group Inc. | 4,24 % | 0,58 % | -1,71 % | 6,17 % | 31,30 % | -6,01 % | -29,81 % |
News
National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company’s
Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer
NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization’s first
National Research Corporation Announces Fourth Quarter and Calendar Year 2023 Results
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023.
CEO Commentary
Michael Hays, Chief Executive Officer, commented: “We’re